Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo (Q40073564)
scientific article
Language:
Current Data About Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
(P31) (Q13442814)
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P50) (Q6390246)
(P1545) 10
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(Q125349428)
(P1545) 5
(P1932) Erin Sargent
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P304) 9417-9424
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P407) (Q1860)

(P433) 19
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P478) 67
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P577) Monday, October 1, 2007
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P921) (Q79460)
(P887)

(Q181257)
(P887)

(P1433) (Q326097)
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P1476) "Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo" (language: en)
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

(P2093) Robert D Loberg
(P1545) 1
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Chi Ying
(P1545) 2
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Matt Craig
(P1545) 3
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Lashon L Day
(P1545) 4
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Chris Neeley
(P1545) 6
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Kirk Wojno
(P1545) 7
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Linda A Snyder
(P1545) 8
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

Li Yan
(P1545) 9
(P248)
(P698) 17909051
(P813) Sunday, September 17, 2017

other details
description scientific article

External Links
(P356) 10.1158/0008-5472.CAN-07-1286
(P698) 17909051
(P5875) 5936103